<DOC>
	<DOCNO>NCT00366119</DOCNO>
	<brief_summary>The purpose study assess drug effective Ramiprin® ( ramipril ) Tritace® ( ramipril ) Treatment Essential Hypertension</brief_summary>
	<brief_title>Safety Efficacy Ramipril Treatment Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<criteria>mild moderate essential hypertension ( 90mmHg≤DBP≤110mmHg ) 180mmHg≤SBP If difference great 20mmHg SBP 10mmHg DBP arm present 3 consecutive reading If difference great 20mmHg SBP 10mmHg DBP present 3 consecutive reading impair hepatic function imapaired renal function angioedema aortic valvular stenosis obstrcutive ejection disorder primary hyperaldosteronism renal transplantation , bilateral renal artery stenosis unilateral stenosis single kidney , hemodialysis severe respiratory disease congestive heart failure ( New York Association functional class Ⅲ Ⅳ ) malignant hypertension labile angina pectoris myocardial infarction last 3 month study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>hypertension</keyword>
	<keyword>ramipril</keyword>
	<keyword>blood pressure</keyword>
	<keyword>artery stiffness</keyword>
	<keyword>BNP</keyword>
	<keyword>CRP</keyword>
</DOC>